Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial.
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, de Oliveira JV, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Lepski G, et al. Among authors: barbuto jam. Cancers (Basel). 2023 Feb 15;15(4):1239. doi: 10.3390/cancers15041239. Cancers (Basel). 2023. PMID: 36831580 Free PMC article.
Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence.
Pinho MP, Lepski GA, Rehder R, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow EA, de Oliveira JV, Fogolin CS, Peres N, Arévalo A, Alves V, Barbuto JAM, Bergami-Santos PC. Pinho MP, et al. Among authors: barbuto jam. Int J Mol Sci. 2022 May 12;23(10):5396. doi: 10.3390/ijms23105396. Int J Mol Sci. 2022. PMID: 35628206 Free PMC article.
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States.
Schimke LF, Marques AHC, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, Rodrigues Plaça D, Salerno Filgueiras I, Coelho Salgado R, Jansen-Marques G, Rocha Oliveira AE, Peron JPS, Cabral-Miranda G, Barbuto JAM, Camara NOS, Calich VLG, Ochs HD, Condino-Neto A, Overmyer KA, Coon JJ, Balnis J, Jaitovich A, Schulte-Schrepping J, Ulas T, Schultze JL, Nakaya HI, Jurisica I, Cabral-Marques O. Schimke LF, et al. Among authors: barbuto jam. Cells. 2022 Mar 1;11(5):847. doi: 10.3390/cells11050847. Cells. 2022. PMID: 35269470 Free PMC article.
Myeloid Immune Cells CARrying a New Weapon Against Cancer.
Ramos RN, Couto SCF, Oliveira TGM, Klinger P, Braga TT, Rego EM, Barbuto JAM, Rocha V. Ramos RN, et al. Among authors: barbuto jam. Front Cell Dev Biol. 2021 Dec 10;9:784421. doi: 10.3389/fcell.2021.784421. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34977027 Free PMC article. Review.
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants.
Prates-Syed WA, Chaves LCS, Crema KP, Vuitika L, Lira A, Côrtes N, Kersten V, Guimarães FEG, Sadraeian M, Barroso da Silva FL, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Cabral-Miranda G. Prates-Syed WA, et al. Among authors: barbuto jam. Vaccines (Basel). 2021 Nov 30;9(12):1409. doi: 10.3390/vaccines9121409. Vaccines (Basel). 2021. PMID: 34960155 Free PMC article. Review.
91 results